Loading...
Loading...
BDXB| Name | Value |
|---|---|
| Revenues | 4,586.0M |
| Cost of Revenue | 2,453.0M |
| Gross Profit | 2,133.0M |
| Operating Expense | 1,503.0M |
| Operating I/L | 585.0M |
| Other Income/Expense | -104.0M |
| Interest Income | 6.0M |
| Pretax | 481.0M |
| Income Tax Expense | -28.0M |
| Net Income/Loss | 509.0M |
Becton, Dickinson and Company is a global leader in the development, manufacturing, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company's BD Medical segment offers a wide range of medical products including IV catheters, drug delivery systems, diabetes care products, and sharps disposal systems. BD Life Sciences segment provides specimen and blood collection products, microbiology laboratory automation products, and diagnostic assays. The BD Interventional segment offers surgical and infection prevention products, peripheral intervention products, and urology and critical care products. The company generates revenue through the sale of these medical and diagnostic products to healthcare institutions, physicians, and the general public worldwide.
